A study to know the effect of lajjalu drug rectal medicine in the treatment of piles

A controlled clinical study to evaluate the efficacy of lajjalu suppository in the management of Abhyantara Arshas(first and second degree internal haemorrhoids) - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089749

Enrollment

Registered

2025-06-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with 1st 2nd degree internal haemorrhoids maximum 3 primary internal Haemorrhoids. Hb more than 8mg dl.

Exclusion criteria

Exclusion criteria: External and Thrombsed pile mass 3rd and 4th degree internal haemorrhoids Patients with HIV and HBsAG positive Patients suffering from DM Hypertension and Tuberculosis Crohns disease CA of rectum and ulcerative colitis Along with fistula and fissure in ano

Design outcomes

Primary

Measure	Time frame
reduction in size and number of pile mass cessation of ano rectal bleedingTimepoint: 15 days	—

Secondary

Measure	Time frame
correct suppository is more effective in comparison to lajjalu suppositoryTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Geetanjali Hiremath

Shree jagadguru gavisiddeshwara ayurvedic medical college and hospital koppal

sanjalihiremath@gmail.com7760346752

Outcome results